|
1
|
Karavitaki N: Prevalence and incidence of
pituitary adenomas. Ann Endocrinol (Paris). 73:79–80. 2012.
View Article : Google Scholar
|
|
2
|
Aflorei ED and Korbonits M: Epidemiology
and etiopathogenesis of pituitary adenomas. J Neurooncol.
117:379–394. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kokshoorn NE, Romijn JA, Roelfsema F,
Rambach AH, Smit JW, Biermasz NR and Pereira AM: The use of an
early postoperative CRH test to assess adrenal function after
transsphenoidal surgery for pituitary adenomas. Pituitary.
15:436–444. 2012. View Article : Google Scholar :
|
|
4
|
Feelders RA, de Bruin C, Pereira AM,
Romijn JA, Netea-Maier RT, Hermus AR, Zelissen PM, van Heerebeek R,
de Jong FH, van der Lely AJ, et al: Pasireotide alone or with
cabergoline and ketoconazole in Cushing's disease. N Engl J Med.
362:1846–1848. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Biller BM, Grossman AB, Stewart PM, Melmed
S, Bertagna X, Bertherat J, Buchfelder M, Colao A, Hermus AR,
Hofland LJ, et al: Treatment of adrenocorticotropin-dependent
Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab.
93:2454–2462. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Newell-Price J, Bertagna X, Grossman AB
and Nieman LK: Cushing's syndrome. Lancet. 367:1605–1617. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tritos NA, Biller BM and Swearingen B:
Management of Cushing disease. Nat Rev Endocrinol. 7:279–289. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gong J, Diao B, Yao GJ, Liu Y and Xu GZ:
Analysis of regulatory networks constructed based on gene
coexpression in pituitary adenoma. J Genet. 92:489–497. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lampichler K, Ferrer P, Vila G, et al: The
role of GLI1 in pituitary tumor formation and pituitary cell
survival. 2013.
|
|
10
|
Cazabat L, Bouligand J and Chanson P: AIP
mutation in pituitary adenomas. N Engl J Med. 364:1973–1974. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Riester A, Issler O, Spyroglou A, Rodrig
SH, Chen A and Beuschlein F: ACTH-dependent regulation of microRNA
as endogenous modulators of glucocorticoid receptor expression in
the adrenal gland. Endocrinology. 153:212–222. 2012. View Article : Google Scholar
|
|
12
|
Vierimaa O, Georgitsi M, Lehtonen R,
Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM,
Salmela PI, Paschke R, et al: Pituitary adenoma predisposition
caused by germline mutations in the AIP gene. Science.
312:1228–1230. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article3. 2004.
|
|
15
|
BRIDGES JRCC: Hierarchical cluster
analysis. Psychological reports. 18:851–854. 1966. View Article : Google Scholar
|
|
16
|
Team RC: R: A language and environment for
statistical computing. 2012.
|
|
17
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: Two different approaches for gene ontology
analysis. BMC Proc. 3(Suppl 4): S102009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Altermann E and Klaenhammer TR:
PathwayVoyager: Pathway mapping using the kyoto encyclopedia of
genes and genomes (KEGG) database. BMC Genomics. 6:602005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, Kirov S and Snoddy J: WebGestalt:
An integrated system for exploring gene sets in various biological
contexts. Nucleic Acids Res. 33:W741–W748. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duncan D, Prodduturi N and Zhang B:
WebGestalt2: An updated and expanded version of the Web-based Gene
Set Analysis Toolkit. Bmc Bioinformatics. 11(Suppl 4): P102010.
View Article : Google Scholar
|
|
22
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39:D561–D568. 2011. View Article : Google Scholar :
|
|
23
|
Kohl M, Wiese S and Warscheid B:
Cytoscape: Software for visualization and analysis of biological
networks. Methods Mol Biol. 696:291–303. 2011. View Article : Google Scholar
|
|
24
|
Lamb J: The Connectivity Map: A new tool
for biomedical research. Nat Rev Cancer. 7:54–60. 2007. View Article : Google Scholar
|
|
25
|
Lamb J, Crawford ED, Peck D, Modell JW,
Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et
al: The Connectivity Map: Using gene-expression signatures to
connect small molecules, genes and disease. Science. 313:1929–1935.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vierimaa O, Georgitsi M, Lehtonen R,
Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM,
Salmela PI, Paschke R, et al: Pituitary adenoma predisposition
caused by germline mutations in the AIP gene. Science.
312:1228–1230. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nagano O and Saya H: Mechanism and
biological significance of CD44 cleavage. Cancer Sci. 95:930–935.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tsukita S, Oishi K, Sato N, Sagara J,
Kawai A and Tsukita S: ERM family members as molecular linkers
between the cell surface glycoprotein CD44 and actin-based
cytoskeletons. J Cell Biol. 126:391–401. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lesley J and Hyman R: CD44 can be
activated to function as an hyaluronic acid receptor in normal
murine T cells. Eur J Immunol. 22:2719–2723. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weber GF, Ashkar S, Glimcher MJ and Cantor
H: Receptor-ligand interaction between CD44 and osteopontin
(Eta-1). Science. 271:509–512. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ponta H, Sherman L and Herrlich PA: CD44:
from adhesion molecules to signalling regulators. Nat Rev Mol Cell
Biol. 4:33–45. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Toole BP: Hyaluronan: From extracellular
glue to pericellular cue. Nat Rev Cancer. 4:528–539. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jaracz S, Chen J, Kuznetsova LV and Ojima
I: Recent advances in tumor-targeting anticancer drug conjugates.
Bioorg Med Chem. 13:5043–5054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frank S, Rihs H-P, Stöcker W, Müller J,
Dumont B, Baur X, Schackert HK and Schackert G: Combined detection
of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry
in primary human brain tumors and brain metastases. Biochem Biophys
Res Commun. 222:794–801. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Duan Bo ZH and Li Xinjian: Expression and
relationship between CD44 and Ki-67 in invasive pituitary adenomas.
Cancer Res Prev Treat. 33:490–492. 2006.
|
|
36
|
Rubinfeld H, Cohen-Kaplan V, Nass D, Ilan
N, Meisel S, Cohen ZR, Hadani M, Vlodavsky I and Shimon I:
Heparanase is highly expressed and regulates proliferation in
GH-secreting pituitary tumor cells. Endocrinology. 152:4562–4570.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pan Y, Han C, Wang C, Hu G, Luo C, Gan X,
Zhang F, Lu Y and Ding X: ADAM10 promotes pituitary adenoma cell
migration by regulating cleavage of CD44 and L1. J Mol Endocrinol.
49:21–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roessler E, Du YZ, Mullor JL, Casas E,
Allen WP, Gillessen-Kaesbach G, Roeder ER, Ming JE, Ruiz i Altaba A
and Muenke M: Loss-of-function mutations in the human GLI2 gene are
associated with pituitary anomalies and holoprosencephaly-like
features. Proc Natl Acad Sci USA. 100:13424–13429. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Devine CA, Sbrogna JL, Guner B, Osgood M,
Shen MC and Karlstrom RO: A dynamic Gli code interprets Hh signals
to regulate induction, patterning and endocrine cell specification
in the zebrafish pituitary. Dev Biol. 326:143–154. 2009. View Article : Google Scholar
|
|
41
|
Vila G, Theodoropoulou M, Stalla J, Tonn
JC, Losa M, Renner U, Stalla GK and Paez-Pereda M: Expression and
function of sonic hedgehog pathway components in pituitary
adenomas: Evidence for a direct role in hormone secretion and cell
proliferation. J Clin Endocrinol Metab. 90:6687–6694. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ruiz i Altaba A, Palma V and Dahmane N:
Hedgehog-Gli signalling and the growth of the brain. Nat Rev
Neurosci. 3:24–33. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
43
|
Matsumoto M, Matsutani S, Sugita K,
Yoshida H, Hayashi F, Terui Y, Nakai H, Uotani N, Kawamura Y and
Matsumoto K: Depudecin: A novel compound inducing the flat
phenotype of NIH3T3 cells doubly transformed by ras-and
src-oncogene, produced by Alternaria brassicicola. J Antibiot
(Tokyo). 45:879–885. 1992. View Article : Google Scholar
|
|
44
|
Oikawa T, Onozawa C, Inose M and Sasaki M:
Depudecin, a microbial metabolite containing two epoxide groups,
exhibits anti-angiogenic activity in vivo. Biol Pharm Bull.
18:1305–1307. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shimada J, Kwon HJ, Sawamura M and
Schreiber SL: Synthesis and cellular characterization of the
detransformation agent, (−)-depudecin. Chem Biol. 2:517–525. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kwon HJ, Owa T, Hassig CA, Shimada J and
Schreiber SL: Depudecin induces morphological reversion of
transformed fibroblasts via the inhibition of histone deacetylase.
Proc Natl Acad Sci USA. 95:3356–3361. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen H and Kunnimalaiyaan M: Modulating
notch1 signaling pathway for treating neuroendocrine tumors. US
Patent 8338482 B2. Filed July 20, 2007; issued December 25,
2012.
|
